Partner Therapeutics recalls

FDA enforcement reports naming Partner Therapeutics Inc as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Jul 21, 2021

Severity

Jul 21, 2021LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per b…Drug · Partner Therapeutics IncFAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.Class III